ADx NeuroSciences

Foundation date

2011-09-16

Sector

#Biotechnology - Therapeutics

Subsector

We create tailor-made antibodies and assays to quantify unique biomarkers in a wide variety of neurodegenerative diseases and conditions such as Alzheimer’s disease, Parkinson’s disease and traumatic brain injury. Our assays enable early detection before symptoms appear, providing valuable information from the drug development phase up to clinical practice, to improve the life of patients.

Upcoming events

Latest news

  • Nomination of Christophe Maréchal as interim CEO

    10 hours ago

  • Biotalys submits first protein-based biocontrol registration package to the EPA

    10 hours ago

  • Targeting Tau to keep neurons connected

    1 day ago